SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001116502-03-000113
Filing Date
2003-02-07
Accepted
2003-02-07 15:46:38
Documents
1
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL STATEMENT-CHANGES IN BENEFICIAL OWNERSHIP medimmune-5.txt 5 9352
  Complete submission text file 0001116502-03-000113.txt   11397
Mailing Address 35 W WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address 35 W WATKINS MILL RD GAITHERSBURG MD 20878 3014170770
MEDIMMUNE INC /DE (Subject) CIK: 0000873591 (see all company filings)

IRS No.: 521555759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 5 | Act: 34 | File No.: 001-14657 | Film No.: 03544786
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 44 NASSAU ST PRINCETON NJ 08542
Business Address 44 NASSAU ST PRINCETON NJ 08542 6094303930
CAVANAUGH JAMES H (Reporting) CIK: 0001013473 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 0731
SIC: 0000